SG
AIFF

StoneX Group’s Firefly Neuroscience AIFF Stock Holding History

StoneX Group’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,611
Closed -$14.7K – 745
2023
Q2 		$14.7K Buy
+1,611
New +$18.2K ﹤0.01% 569

Other funds holding AIFF

LI
Lafayette Investments Ashton, Maryland $542M AUM 22.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

StoneX Group's AIFF Position: Q3 2023 in Review

StoneX Group sold out of Firefly Neuroscience (AIFF) in Q3 2023, closing a stake of 1,611 shares — an estimated $14.7K sold.

StoneX Group first reported a position in AIFF in Q2 2023 and held it in 1 quarter. The position peaked at $14.7K in Q2 2023. 12 funds tracked by Wall St. Rank hold AIFF as of Q3 2023.

  • StoneX Group reported no remaining Firefly Neuroscience position as of Q3 2023 after selling out during the quarter.
  • StoneX Group sold 1,611 Firefly Neuroscience shares in Q3 2023, an estimated $14.7K.
  • StoneX Group first reported a position in Firefly Neuroscience in Q2 2023 and held it in 1 quarter.
  • StoneX Group's Firefly Neuroscience position peaked at $14.7K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q3 2023.

Based on StoneX Group's 13F filing for Q3 2023, filed 15 Nov 2023.